GT BiopharmaGTBP
那斯達克 · USD
0.45
+0.01
(+2.76%)
收盤 06/13 03:54 (UTC+8)
06/13 03:54 (UTC+8)
GT BiopharmaGTBP
0.45
+0.01
(+2.76%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 2,848 | 5,595 | 3,382 | 1,513 | 1,932 | 3,763 | 3,604 | 3,906 | 3,091 | 3,168 |
研發費用 | 413 | 1,376 | 634 | 363 | 1,099 | 1,930 | 1,307 | 1,784 | 777 | 1,357 |
推銷及管理費用 | 2,435 | 4,219 | 2,748 | 1,150 | 833 | 1,833 | 2,297 | 2,122 | 2,314 | 1,811 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -2,848 | -5,595 | -3,382 | -1,513 | -1,932 | -3,763 | -3,604 | -3,906 | -3,091 | -3,168 |
其他收入及費用 | 78 | 14 | 11,681 | -28,656 | 1,156 | -12 | 193 | 196 | 825 | 206 |
利息費用 | 63 | 127 | - | - | - | - | - | - | - | - |
稅前純益 | -2,833 | -5,708 | 8,299 | -30,169 | -776 | -3,775 | -3,411 | -3,710 | -2,266 | -2,962 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -2,833 | -5,708 | 8,299 | -30,169 | -776 | -3,775 | -3,411 | -3,710 | -2,266 | -2,962 |
基本每股稅後盈餘(元) | -0.11 | -4.97 | 1.04 | -10.92 | -0.33 | -1.60 | -1.53 | -2.17 | -1.64 | - |
稀釋每股稅後盈餘(元) | -0.11 | 2.22 | 3.22 | -11.79 | -0.33 | -1.66 | -1.42 | -2.22 | -1.64 | -0.07 |
基本平均股數(千股) | 30283.00 | 12997.00 | 3940.00 | 2771.00 | 2345.00 | 2264.00 | 2234.00 | 1711.00 | 1380.00 | - |
稀釋平均股數(千股) | 30283.00 | 12997.00 | 3940.00 | 2771.00 | 2345.00 | 2264.00 | 2234.00 | 1711.00 | 1380.00 | - |
還原基本每股稅後盈餘(元) | -0.11 | -4.97 | 1.04 | -10.92 | -0.33 | -1.60 | -1.53 | -2.17 | -1.64 | - |
還原稀釋每股稅後盈餘(元) | -0.11 | 2.22 | 3.22 | -11.79 | -0.33 | -1.66 | -1.42 | -2.22 | -1.64 | -2.17 |
還原基本平均股數(千股) | 30,283 | 12,997 | 3,940 | 2,771 | 2,345 | 2,264 | 2,234 | 1,711 | 1,380 | - |
還原稀釋平均股數(千股) | 30,283 | 12,997 | 3,940 | 2,771 | 2,345 | 2,264 | 2,234 | 1,711 | 1,380 | - |
EBITDA(千元) | -2,770 | -5,581 | 8,299 | -30,169 | -776 | -3,775 | -3,411 | -3,710 | -2,266 | -2,962 |